Recruiting soon

Cognitive Behavioural and Metacognitive Therapy for Low Self-Esteem

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Cognitive behavioral therapy

+ Metacognitive therapy

Behavioral
Who is being recruted

Anxiety Disorders+2

+ Behavior

+ Mental Disorders

Over 18 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: March 2025
See protocol details

Summary

Principal SponsorUniversity of Oslo
Study ContactRoger Hagen, ProfessorMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2025

Actual date on which the first participant was enrolled.

This clinical trial focuses on comparing two types of therapy, Cognitive Behavioural Therapy (CBT) and Meta Cognitive Therapy (MCT), to help people with low self-esteem. Low self-esteem is linked to various mental health issues and can significantly affect one's quality of life. This study is important because it aims to find out which therapy might be more effective in improving self-esteem and mental health outcomes. While CBT has been studied before, MCT is a newer approach that shows promise in treating other disorders, and its effectiveness for low self-esteem has not been thoroughly tested yet. In the study, 20 participants with low self-esteem will be divided into two groups. One group will receive MCT, and the other will undergo CBT. During the study, participants will be evaluated at the start, at the end of the treatment, and six months afterwards to assess changes in their self-esteem and mental health. They will also have weekly assessments to monitor progress. The trial will help determine the accessibility and effectiveness of these therapies and study how the treatments work, aiming to prevent self-esteem issues from returning. There are no specific risks mentioned, but the benefits could lead to better mental health and improved life quality for those with low self-esteem.

Official TitleCognitive Behavioural Therapy/Metacognitive Therapy for Low Self Esteem
NCT06866639
Principal SponsorUniversity of Oslo
Study ContactRoger Hagen, ProfessorMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Anxiety DisordersBehaviorMental DisordersBehavioral SymptomsDepression

Criteria

3 inclusion criteria required to participate
Signed written informed consent obtained prior to entry in the study.
Scores below 15 on the Rosenberg Self-esteem Scale (RSE)
18 years or older.
6 exclusion criteria prevent from participating
Substance dependence
Psychosis
Bipolar type 1
Current suicide intent
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Cognitive behavioral therapy

Group II

Experimental
Metacognitive therapy

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Department of Psychology, University of Oslo

Oslo, NorwayOpen Department of Psychology, University of Oslo in Google Maps
Recruiting soonOne Study Center